Skip to main content
Signal8

Wolfe Peter

SEC insider (Form 3/4/5 filer). CIK 0001954398. Chief Financial Officer at ZyVersa Therapeutics, Inc. (ZVSA). 1 reported Form 4/5 transaction since Sep 2024; latest on Jul 11, 2025. Located in WESTON, FL.

Companies Wolfe Peter has filed insider reports for

  • ZyVersa Therapeutics, Inc. (ZVSA): Officer, Chief Financial Officer
Wolfe Peter profile photo

Wolfe Peter

CIK: 0001954398

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ZyVersa Therapeutics, Inc. logo
ZVSA

ZyVersa Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ZyVersa Therapeutics, Inc. logo
    ZVSA

    ZyVersa Therapeutics, Inc.

    Jul 11, 2025
    Award

    Stock Options

    Direct
    60.1K shares-

1-1 of 1